MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$72,869K
(-23.31%↓ Y/Y)
Net loss
-$71,598K
(-2.05%↓ Y/Y)
Total other
comprehensive (loss) income,...
-$1,271K
(-111.48%↓ Y/Y)
Net loss before
income tax
-$70,735K
(-4.12%↓ Y/Y)
Income tax expense
$863K
(-61.21%↓ Y/Y)
Foreign currency
exchange translation...
-$1,130K
(-110.59%↓ Y/Y)
Unrealized holding
(losses) gains on...
-$141K
(-135.25%↓ Y/Y)
Loss from operations
-$59,513K
(8.78%↑ Y/Y)
Total other
(expenses) income, net
-$11,222K
(-316.25%↓ Y/Y)
Total revenue, net
$26,218K
(191.89%↑ Y/Y)
Interest income
$2,469K
(-59.77%↓ Y/Y)
Other income, net
$100K
(-22.48%↓ Y/Y)
Selling, general and
administrative expenses
$39,953K
(35.28%↑ Y/Y)
Cost of sales
$24,568K
(36.86%↑ Y/Y)
Interest expense, net
$11,124K
(9.67%↑ Y/Y)
Foreign exchange
(losses) gains, net
-$2,667K
(-325.83%↓ Y/Y)
Research and development
expenses, net
$21,210K
(-20.66%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL)